A quasi-randomized clinical trial of tapentadol versus oxycodone for initial control of moderate cancer-related pai
Phase 4
- Conditions
- Malignant neoplasm
- Registration Number
- JPRN-UMIN000018954
- Lead Sponsor
- Kansai Electric Power Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with previously receiving strong opioid analgesic administration. Patient with severe cancer-related pain (NRS 9-10 and/or STAS-J 4)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method